A Reimbursement Intelligence Product
Navigating onerous reimbursement processes can be difficult for both healthcare practices and patients. Addressing this challenge thoughtfully and effectively can have a substantial impact on the commercial success of your drug.
How does my program stack up
vs. competitors?
What are my customers’ biggest pain
points and how can I better address
them?
Which elements have the greatest
influence on initial product selection?
Reduce stress for patients and
caregivers
Help staff navigate medication process
Improve patient adherence
Reduce time to fulfillment
A biotech company commissioned a Hub Excellence diagnostic six months after significant program enhancements.
Only 3% aware of “no income restriction” aspect of co-pay program.
Survey respondents indicated that co-pay programs and patient assistance are by far the leading program elements contributing to initial product selection.
The client had, in fact, removed all income restrictions from its co-pay program six months prior.
Yet, only 3% of survey respondents were aware of the “no income restriction” aspect, despite significant investment in the design and rollout of the enhanced co-pay program.
1
Client called emergency
meeting for entire sales
force and told them to
make the co-pay program
a top talking point.
2
Reimbursement Intelligence
helped refine messaging and
communication materials.
3
Reimbursement Intelligence
plans to repeat Hub Excellence
analysis to:
Senior Director
Specialty Access Solutions, Top 5 Pharma
Director of Operations
Reimbursement and Patient Support Services, Top 20 Pharma